89 related articles for article (PubMed ID: 1382603)
1. Mapping of the epitope on lipoprotein lipase recognized by a monoclonal antibody (5D2) which inhibits lipase activity.
Liu MS; Ma Y; Hayden MR; Brunzell JD
Biochim Biophys Acta; 1992 Sep; 1128(1):113-5. PubMed ID: 1382603
[TBL] [Abstract][Full Text] [Related]
2. Detailed characterization of the binding site of the lipoprotein lipase-specific monoclonal antibody 5D2.
Chang SF; Reich B; Brunzell JD; Will H
J Lipid Res; 1998 Dec; 39(12):2350-9. PubMed ID: 9831623
[TBL] [Abstract][Full Text] [Related]
3. Identification of the epitope of a monoclonal antibody that inhibits heparin binding of lipoprotein lipase: new evidence for a carboxyl-terminal heparin-binding domain.
Sendak RA; Melford K; Kao A; Bensadoun A
J Lipid Res; 1998 Mar; 39(3):633-46. PubMed ID: 9548595
[TBL] [Abstract][Full Text] [Related]
4. Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies.
Kawamura M; Gotoda T; Mori N; Shimano H; Kozaki K; Harada K; Shimada M; Inaba T; Watanabe Y; Yazaki Y
J Lipid Res; 1994 Sep; 35(9):1688-97. PubMed ID: 7528764
[TBL] [Abstract][Full Text] [Related]
5. The structural basis for monoclonal antibody 5D2 binding to the tryptophan-rich loop of lipoprotein lipase.
Luz JG; Beigneux AP; Asamoto DK; He C; Song W; Allan CM; Morales J; Tu Y; Kwok A; Cottle T; Meiyappan M; Fong LG; Kim JE; Ploug M; Young SG; Birrane G
J Lipid Res; 2020 Oct; 61(10):1347-1359. PubMed ID: 32690595
[TBL] [Abstract][Full Text] [Related]
6. Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies.
Peterson J; Fujimoto WY; Brunzell JD
J Lipid Res; 1992 Aug; 33(8):1165-70. PubMed ID: 1279089
[TBL] [Abstract][Full Text] [Related]
7. Quantification of lipoprotein lipase (LPL) by dissociation-enhanced lanthanide fluorescence immunoassay. Comparison of immunoreactivity of LPL mass and enzyme activity of LPL.
Wicher I; Sattler W; Ibovnik A; Kostner GM; Zechner R; Malle E
J Immunol Methods; 1996 Jun; 192(1-2):1-11. PubMed ID: 8699004
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody against human lipoprotein lipase inhibiting heparin binding without affecting catalytic activity.
Cadelis F; Julien P; Valet JP; Deshaies Y; Ven Murthy MR; Lupien PJ
Biochem Cell Biol; 1996; 74(3):383-9. PubMed ID: 8883844
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a direct sandwich enzyme-linked immunosorbent assay for the quantification of lipoprotein lipase mass in human plasma.
Kimura H; Ohkaru Y; Katoh K; Ishii H; Sunahara N; Takagi A; Ikeda Y
Clin Biochem; 1999 Feb; 32(1):15-23. PubMed ID: 10074887
[TBL] [Abstract][Full Text] [Related]
10. Defective enzyme protein in lipoprotein lipase deficiency.
Auwerx JH; Babirak SP; Fujimoto WY; Iverius PH; Brunzell JD
Eur J Clin Invest; 1989 Oct; 19(5):433-7. PubMed ID: 2511019
[TBL] [Abstract][Full Text] [Related]
11. Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.
Ross CJ; Twisk J; Bakker AC; Miao F; Verbart D; Rip J; Godbey T; Dijkhuizen P; Hermens WT; Kastelein JJ; Kuivenhoven JA; Meulenberg JM; Hayden MR
Hum Gene Ther; 2006 May; 17(5):487-99. PubMed ID: 16716106
[TBL] [Abstract][Full Text] [Related]
12. Rapid and simple isolation procedure for lipoprotein lipase from human milk.
Zechner R
Biochim Biophys Acta; 1990 May; 1044(1):20-5. PubMed ID: 2340307
[TBL] [Abstract][Full Text] [Related]
13. Mutation of tryptophan residues in lipoprotein lipase. Effects on stability, immunoreactivity, and catalytic properties.
Lookene A; Groot NB; Kastelein JJ; Olivecrona G; Bruin T
J Biol Chem; 1997 Jan; 272(2):766-72. PubMed ID: 8995362
[TBL] [Abstract][Full Text] [Related]
14. Production and use of an inhibitory monoclonal antibody to human lipoprotein lipase.
Goldberg IJ; Paterniti JR; France DS; Martinelli G; Cornicelli JA
Biochim Biophys Acta; 1986 Sep; 878(2):168-76. PubMed ID: 3756191
[TBL] [Abstract][Full Text] [Related]
15. Regulation of lipoprotein lipase immunoreactive mass in isolated human adipocytes.
Kern PA; Ong JM; Goers JW; Pedersen ME
J Clin Invest; 1988 Feb; 81(2):398-406. PubMed ID: 3276727
[TBL] [Abstract][Full Text] [Related]
16. Distinct immunoreactivities suggest the existence of potential tissue variants in rat lipoprotein lipase.
Soteriou A; Cryer A
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):417-23. PubMed ID: 8172602
[TBL] [Abstract][Full Text] [Related]
17. Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues.
Lutz EP; Merkel M; Kako Y; Melford K; Radner H; Breslow JL; Bensadoun A; Goldberg IJ
J Clin Invest; 2001 May; 107(9):1183-92. PubMed ID: 11342582
[TBL] [Abstract][Full Text] [Related]
18. Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia.
Kern PA; Martin RA; Carty J; Goldberg IJ; Ong JM
J Lipid Res; 1990 Jan; 31(1):17-26. PubMed ID: 2313202
[TBL] [Abstract][Full Text] [Related]
19. Not the mature 56 kDa lipoprotein lipase protein but a 37 kDa protein co-purifying with the lipase mediates the binding of low density lipoproteins to J774 macrophages.
Hendriks WL; Van Vark LC; Schoonderwoerd K; Jansen H; Havekes LM
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):765-9. PubMed ID: 9480888
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia.
Moret M; Pruneta-Deloche V; Sassolas A; Marcais C; Moulin P
Atherosclerosis; 2010 Feb; 208(2):324-7. PubMed ID: 19695572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
